Document is current

Any future updates will be listed below

Dipeptidyl peptidase-4 inhibitor decreases the risk of atrial fibrillation in patients with type 2 diabetes: a nationwide cohort study in Taiwan

Crossref DOI link: https://doi.org/10.1186/s12933-017-0640-5

Published Online: 2017-12-19

Published Print: 2017-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark